GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
Gold stocks down as metal and equities momentum fades
September 02, 2024 / www.canadianminingreport.com
Another Kazatomprom guidance announcement shakes uranium price
September 02, 2024 / www.canadianminingreport.com
Major monetary drivers still supporting gold
August 26, 2024 / www.canadianminingreport.com
Gold stocks gain on metal rise and continued equities rebound
August 26, 2024 / www.canadianminingreport.com
Big Gold stocks outperform Big Base Metals
August 19, 2024 / www.canadianminingreport.com